Stage-dependent prognostic value of systemic inflammatory biomarkers in early triple-negative breast cancer (TNBC)

被引：0
|
作者：
Marta, G. Nader [1 ]
Tiecher, R. Dahmer [1 ]
Vicentini, M. F. Batistuzzo [1 ]
Dornellas, A. [1 ]
Hoff, P. M. [1 ]
Testa, L. [1 ]
机构：
[1] ICESP Inst Canc Estado Sao Paulo, Dept Med Oncol, Sao Paulo, Brazil
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.453
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
172P
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [1] Prognostic value of systemic inflammatory response in early-stage triple-negative breast cancer.
    Ovcaricek, Tanja
    Matos, Erika
    Auprih, Masa
    Borstnar, Simona
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] The Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer (TNBC)
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    MODERN PATHOLOGY, 2016, 29 : 72A - 72A
  • [3] The Prognostic Value of E-Cadherin and β-Catenin in Triple-Negative Breast Cancer (TNBC)
    Shen, Tiansheng
    Siegal, Gene P.
    Wei, Shi
    LABORATORY INVESTIGATION, 2016, 96 : 72A - 72A
  • [4] The landscape of systemic therapy for early stage triple-negative breast cancer
    Lu, Jin-Yu
    Soto, Alvaro Alvarez
    Anampa, Jesus D.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (11) : 1291 - 1303
  • [5] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [6] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [7] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Minghui Zhang
    Xiaosan Zhang
    Shu Zhao
    Yan Wang
    Wenyu Di
    Gangling Zhao
    Maopeng Yang
    Qingyuan Zhang
    Targeted Oncology, 2014, 9 : 349 - 357
  • [8] Prognostic value of survivin and EGFR protein expression in triple-negative breast cancer (TNBC) patients
    Zhang, Minghui
    Zhang, Xiaosan
    Zhao, Shu
    Wang, Yan
    Di, Wenyu
    Zhao, Gangling
    Yang, Maopeng
    Zhang, Qingyuan
    TARGETED ONCOLOGY, 2014, 9 (04) : 349 - 357
  • [9] Triple-negative breast cancer (TNBC) phosphoproteomics
    Gaitero, Sara Fernandez
    Zagorac, Ivana
    Lopez-Acosta, Jose Francisco
    Gomez-Lopez, Gonzalo
    Pisano, David Gonzalez
    Peralta, Javier Munoz
    Manso, Luis
    Alonso, Soledad
    Penning, Renske
    Altelaar, Maarten
    Heck, Albert J. R.
    Quintela-Fandino, Miguel
    CANCER RESEARCH, 2017, 77
  • [10] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
12345